Compare Recursion Pharmaceuticals Inc (RXRX) vs Ryanair Holdings plc (RYAAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Recursion Pharmaceuticals Inc vs Ryanair Holdings plc — how do they compare? Recursion Pharmaceuticals Inc trades at $3.08 (market cap $1.53B), while Ryanair Holdings plc trades at $58.99 (market cap $29.31B). The key difference: Ryanair Holdings plc is far larger — about 19.2× Recursion Pharmaceuticals Inc's market cap, and Ryanair Holdings plc pays a 1.68% dividend while Recursion Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| RXRX | RYAAY | |
|---|---|---|
Market Cap | $1.53B | $29.31B |
Sector | Health | Industrials |
52-Week High | $6.79 | $73.82 |
52-Week Low | $2.84 | $53.24 |
Enterprise Value | $946.50M | $26.33B |
Dividend Yield | — | 1.68% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →About Ryanair Holdings plc
Ryanair is the leading airline group by passenger numbers in Europe. The company employs a low-cost no-frills model to offer low fares to leisure customers on short-haul intra-European routes. In 2020, the most recent pre-pandemic fiscal year, the company carried 149 million passengers, utilizing a fleet of 467 Boeing 737 aircraft across its 1,800 routes. To keep costs low the company serves predominantly lower-cost secondary airports. The company generated sales of EUR 8.5 billion in fiscal 2020.
Read more on RYAAY →
